{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T18:49:30Z","timestamp":1776106170468,"version":"3.50.1"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3,15]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>As women living with HIV (WLWH) become older, their risk of developing breast cancer increases. Nonetheless, literature is conflicting regarding tumor stage, distribution of subtypes and overall survival among WLWH vs. HIV-negative women with breast cancer. We assessed differences in clinicopathological characteristics and overall survival between these two groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Systematic review and meta-analysis using MEDLINE, Scopus, ISI Web of Knowledge, LILACS, SciELO and conference abstracts up to 1 January 2020. Cross-sectional\/cohort studies comparing baseline characteristics (stage and\/or subtypes) and\/or overall survival of WLWH vs. HIV-negative women with breast cancer were included. We performed random-effects meta-analyses to estimate summary statistics and subgroup analyses according to region of the world.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Eighteen studies [4 from North America, 14 from sub-Saharan Africa (SSA)] were included, with 3174 WLWH and 2\u200a394\u200a598 HIV-negative women. WLWH from North America and SSA were more likely to present with stage III\/IV disease compared with HIV-negative women \u2013 pooled odds ratio (pOR) 1.76 [95% confidence interval (CI):1.58\u20131.95] and pOR 1.23 (95% CI: 1.06\u20131.42), respectively. WLWH from SSA were also less likely to have estrogen receptor-positive\/HER2-negative tumors (pOR 0.81; 95% CI: 0.66\u20130.99). After adjustment, WLWH had worse overall survival compared with HIV-negative women, both in North America [pooled adjusted hazard ratio (aHR) 2.45; 95% CI: 1.11\u20135.41] and SSA (aHR 1.43; 95% CI: 1.06\u20131.92).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Compared with HIV-negative women, WLWH are diagnosed with breast cancer at a more advanced stage and have a worse overall survival. These results should raise awareness regarding the detection and survival gap among WLWH with breast cancer and further studies are needed to decipher the reasons behind these disparities.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/qad.0000000000002810","type":"journal-article","created":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T12:01:58Z","timestamp":1609329718000},"page":"605-618","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":24,"title":["Impact of HIV infection on baseline characteristics and survival of women with breast cancer"],"prefix":"10.1097","volume":"35","author":[{"given":"Mariana","family":"Brand\u00e3o","sequence":"first","affiliation":[{"name":"Institut Jules Bordet, Universit\u00e9 Libre de Bruxelles (ULB), Boulevard de Waterloo, Bruxelles, Belgium"},{"name":"EPIUnit - Instituto de Sa\u00fade P\u00fablica, Universidade do Porto, Rua das Taipas"},{"name":"Departamento de Ci\u00eancias da Sa\u00fade P\u00fablica e Forenses e Educa\u00e7\u00e3o M\u00e9dica, Faculdade de Medicina da Universidade do Porto, Alameda Professor Hern\u00e2ni Monteiro, Porto, Portugal"}]},{"given":"Marco","family":"Bruzzone","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, Genova, Italy"}]},{"given":"Maria-Alice","family":"Franzoi","sequence":"additional","affiliation":[{"name":"Institut Jules Bordet, Universit\u00e9 Libre de Bruxelles (ULB), Boulevard de Waterloo, Bruxelles, Belgium"}]},{"given":"Claudia","family":"De Angelis","sequence":"additional","affiliation":[{"name":"Institut Jules Bordet, Universit\u00e9 Libre de Bruxelles (ULB), Boulevard de Waterloo, Bruxelles, Belgium"}]},{"given":"Daniel","family":"Eiger","sequence":"additional","affiliation":[{"name":"Institut Jules Bordet, Universit\u00e9 Libre de Bruxelles (ULB), Boulevard de Waterloo, Bruxelles, Belgium"}]},{"given":"Rafael","family":"Caparica","sequence":"additional","affiliation":[{"name":"Institut Jules Bordet, Universit\u00e9 Libre de Bruxelles (ULB), Boulevard de Waterloo, Bruxelles, Belgium"}]},{"given":"Martine","family":"Piccart-Gebhart","sequence":"additional","affiliation":[{"name":"Institut Jules Bordet, Universit\u00e9 Libre de Bruxelles (ULB), Boulevard de Waterloo, Bruxelles, Belgium"}]},{"given":"Laurence","family":"Buisseret","sequence":"additional","affiliation":[{"name":"Institut Jules Bordet, Universit\u00e9 Libre de Bruxelles (ULB), Boulevard de Waterloo, Bruxelles, Belgium"}]},{"given":"Marcello","family":"Ceppi","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, Genova, Italy"}]},{"given":"Nicolas","family":"Dauby","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Centre Hospitalier Universitaire Saint-Pierre, Universit\u00e9 Libre de Bruxelles (ULB), Rue Haute, Bruxelles, Belgium"},{"name":"Institute for Medical Immunology, Universit\u00e9 Libre de Bruxelles (ULB), Rue Adrienne Bolland, Gosselies"},{"name":"Centre for Environmental Health and Occupational Health, School of Public Health, Universit\u00e9 Libre de Bruxelles (ULB), Bruxelles, Belgium"}]},{"given":"Carla","family":"Carrilho","sequence":"additional","affiliation":[{"name":"Pathology Department, Faculty of Medicine, University Eduardo Mondlane, Avenida Salvador Allende"},{"name":"Department of Pathology, Maputo Central Hospital, Avenida Eduardo Mondlane, Maputo, Mozambique"}]},{"given":"Nuno","family":"Lunet","sequence":"additional","affiliation":[{"name":"EPIUnit - Instituto de Sa\u00fade P\u00fablica, Universidade do Porto, Rua das Taipas"},{"name":"Departamento de Ci\u00eancias da Sa\u00fade P\u00fablica e Forenses e Educa\u00e7\u00e3o M\u00e9dica, Faculdade de Medicina da Universidade do Porto, Alameda Professor Hern\u00e2ni Monteiro, Porto, Portugal"}]},{"given":"Evandro","family":"de Azambuja","sequence":"additional","affiliation":[{"name":"Institut Jules Bordet, Universit\u00e9 Libre de Bruxelles (ULB), Boulevard de Waterloo, Bruxelles, Belgium"}]},{"given":"Matteo","family":"Lambertini","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, Genova, Italy"},{"name":"University of Genova, Genova, Italy."}]}],"member":"276","published-online":{"date-parts":[[2020,12,30]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"e831","DOI":"10.1016\/S2352-3018(19)30196-1","article-title":"Global, regional, and national incidence, prevalence, and mortality of HIV, 1980\u20132017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017","volume":"6","author":"GBD 2017 HIV collaborators","year":"2019","journal-title":"Lancet HIV"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJMra1615896","article-title":"HIV-associated cancers and related diseases","volume":"378","author":"Yarchoan","year":"2018","journal-title":"N Engl J Med"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1002\/ijc.31722","article-title":"Breast cancer in women living with HIV: a first global estimate","volume":"143","author":"McCormack","year":"2018","journal-title":"Int J Cancer"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/jnci\/djy010","article-title":"Risk of breast, prostate, and colorectal cancer diagnoses among HIV-infected individuals in the United States","volume":"110","author":"Coghill","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijsu.2016.08.520","article-title":"The effect of HIV infection on the surgical, chemo- and radiotherapy management of breast cancer. A prospective cohort study","volume":"34","author":"Phakathi","year":"2016","journal-title":"Int J Surg Lond Engl"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10549-013-2606-y","article-title":"Breast cancer characteristics and HIV among 1,092 women in Soweto, South Africa","volume":"140","author":"Cubasch","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"452","DOI":"10.7326\/0003-4819-153-7-201010050-00008","article-title":"Age at cancer diagnosis among persons with AIDS in the United States","volume":"153","author":"Shiels","year":"2010","journal-title":"Ann Intern Med"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1200\/JGO.2015.002451","article-title":"Phenotype and treatment of breast cancer in HIV-positive and -negative women in Cape Town, South Africa","volume":"2","author":"Langenhoven","year":"2016","journal-title":"J Glob Oncol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/cncr.29324","article-title":"Cancer stage at diagnosis in patients infected with the human immunodeficiency virus and transplant recipients","volume":"121","author":"Shiels","year":"2015","journal-title":"Cancer"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/ijc.31187","article-title":"Drivers of advanced stage at breast cancer diagnosis in the multicountry African breast cancer \u2013 disparities in outcomes (ABC-DO) study","volume":"142","author":"McKenzie","year":"2018","journal-title":"Int J Cancer"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.canep.2017.12.007","article-title":"Breast cancer survival in Soweto, Johannesburg, South Africa: a receptor-defined cohort of women diagnosed from 2009 to 11","volume":"52","author":"Cubasch","year":"2018","journal-title":"Cancer Epidemiol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1097\/01.aids.0000433236.55937.cb","article-title":"Contribution of HIV infection to mortality among cancer patients in Uganda","volume":"27","author":"Coghill","year":"2013","journal-title":"AIDS Lond Engl"},{"key":"R17-20250608","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz101.014","article-title":"213PHIV infection in breast cancer patients from Mozambique: a prospective cohort study","volume":"30","author":"Brand\u00e3o","year":"2019","journal-title":"Ann Oncol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update","volume":"36","author":"Wolff","year":"2018","journal-title":"J Clin Oncol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J Clin Oncol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jnci\/djr393","article-title":"Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer Working Group","volume":"103","author":"Dowsett","year":"2011","journal-title":"JNCI J Natl Cancer Inst"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R24-20250608","first-page":"22","article-title":"Prevalence of HIV\/AIDS among breast cancer patients and the associated clinico-pathological features","volume":"8","author":"Sseggwanyi","year":"2011","journal-title":"Ann Afr Surg"},{"key":"R25-20250608","first-page":"595","article-title":"Incidence of chemotherapy-induced neutropenia in HIV-infected and uninfected patients with breast cancer receiving neoadjuvant chemotherapy","volume":"107","author":"Ngidi","year":"2017","journal-title":"SAMJ South Afr Med J"},{"key":"R26-20250608","first-page":"1","article-title":"Human immunodeficiency virus infection in breast cancer patients: the prevalence thereof and its effect on breast cancer characteristics at Dr George Mukhari Academic Hospital Breast Clinic, Ga-Rankuwa, South Africa","volume":"22","author":"van Zyl","year":"2018","journal-title":"SA J Radiol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1002\/cncr.32158","article-title":"Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base","volume":"125","author":"Coghill","year":"2019","journal-title":"Cancer"},{"key":"R28-20250608","first-page":"261","article-title":"HIV infection in patients with breast cancer in Guinea (West Africa)","volume":"21","author":"Traore","year":"2015","journal-title":"Pan Afr Med J"},{"key":"R29-20250608","first-page":"1009","article-title":"Breast cancer in HIV-positive patients: a multi-institutional retrospective review","volume":"1","author":"Presti","year":"2017","journal-title":"J Prev Med Heal"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7196\/SAMJ.2019.v109i4.13465","article-title":"Prevalence of comorbidities in women with and without breast cancer in Soweto, South Africa: results from the SABC study","volume":"109","author":"Ayeni","year":"2019","journal-title":"S Afr Med J"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.breast.2018.12.005","article-title":"Clinico-pathological characteristics among South African women with breast cancer receiving antiretroviral therapy for HIV","volume":"43","author":"Phakathi","year":"2019","journal-title":"Breast"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13027-019-0245-6","article-title":"Report of clinico-pathological features of breast cancer in HIV-infected and uninfected women in Botswana","volume":"14","author":"Bhatia","year":"2019","journal-title":"Infect Agent Cancer"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1200\/JCO.2014.59.5967","article-title":"Elevated cancer-specific mortality among HIV-infected patients in the United States","volume":"33","author":"Coghill","year":"2015","journal-title":"J Clin Oncol"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.qai.0000164033.02947.e3","article-title":"Survival after cancer diagnosis in persons with AIDS","volume":"39","author":"Biggar","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ctrv.2016.07.006","article-title":"Reproductive behaviors and risk of developing breast cancer according to tumor subtype: a systematic review and meta-analysis of epidemiological studies","volume":"49","author":"Lambertini","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1158\/0008-5472.CAN-18-0502","article-title":"Pooled analysis of nine cohorts reveals breast cancer risk factors by tumor molecular subtype","volume":"78","author":"Gaudet","year":"2018","journal-title":"Cancer Res"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"Denkert","year":"2018","journal-title":"Lancet Oncol"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","year":"2012","journal-title":"Nature"},{"key":"R39-20250608","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju055","article-title":"US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status","volume":"106","author":"Howlader","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"E610","DOI":"10.1210\/jc.2012-3195","article-title":"Gonadotropin and sex steroid levels in HIV-infected premenopausal women and their association with subclinical atherosclerosis in HIV-infected and -uninfected women in the Women's Interagency HIV Study (WIHS)","volume":"98","author":"Karim","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R41-20250608","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/QAD.0000000000002084","article-title":"HIV and amenorrhea: a meta-analysis","volume":"33","author":"King","year":"2019","journal-title":"AIDS"},{"key":"R42-20250608","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju503","article-title":"Excess cancers among HIV-infected people in the United States","volume":"107","author":"Robbins","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"R43-20250608","doi-asserted-by":"crossref","first-page":"e1001720","DOI":"10.1371\/journal.pmed.1001720","article-title":"Receptor-defined subtypes of breast cancer in indigenous populations in Africa: a systematic review and meta-analysis","volume":"11","author":"Eng","year":"2014","journal-title":"PLoS Med"},{"key":"R44-20250608","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1200\/JCO.2013.54.8644","article-title":"Cancer treatment disparities in HIV-infected individuals in the United States","volume":"32","author":"Suneja","year":"2014","journal-title":"J Clin Oncol"},{"key":"R45-20250608","doi-asserted-by":"crossref","first-page":"e923","DOI":"10.1016\/S2214-109X(16)30259-5","article-title":"Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis","volume":"4","author":"Jedy-Agba","year":"2016","journal-title":"Lancet Glob Health"},{"key":"R46-20250608","doi-asserted-by":"crossref","first-page":"100205","DOI":"10.1016\/j.eclinm.2019.11.001","article-title":"Association between HIV infection and outcomes of care among medicare enrollees with breast cancer","volume":"17","author":"Chhatre","year":"2019","journal-title":"EClinicalMedicine"},{"key":"R47-20250608","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13027-017-0124-y","article-title":"An update on the management of breast cancer in Africa","volume":"12","author":"Vanderpuye","year":"2017","journal-title":"Infect Agent Cancer"},{"key":"R48-20250608","doi-asserted-by":"crossref","first-page":"e1203","DOI":"10.1016\/S2214-109X(20)30261-8","article-title":"Breast cancer survival and survival gap apportionment in sub-Saharan Africa (ABC-DO): a prospective cohort study","volume":"8","author":"McCormack","year":"2020","journal-title":"Lancet Glob Health"},{"key":"R49-20250608","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw192","article-title":"Relevance of tumor-infiltrating immune cell composition and functionality for disease outcome in breast cancer","volume":"109","author":"Bense","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"R50-20250608","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","article-title":"Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer","volume":"379","author":"Schmid","year":"2018","journal-title":"N Engl J Med"},{"key":"R51-20250608","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N Engl J Med"},{"key":"R52-20250608","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/cncr.31782","article-title":"Survival after a cancer diagnosis among solid organ transplant recipients in the United States","volume":"125","author":"D\u2019Arcy","year":"2019","journal-title":"Cancer"},{"key":"R53-20250608","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13027-018-0188-3","article-title":"Survival after cancer diagnosis in a cohort of HIV-positive individuals in Latin America","volume":"13","author":"Fink","year":"2018","journal-title":"Infect Agent Cancer"},{"key":"R54-20250608","doi-asserted-by":"crossref","first-page":"e94768","DOI":"10.1371\/journal.pone.0094768","article-title":"Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an Italian Multicenter Study","volume":"9","author":"Gotti","year":"2014","journal-title":"PloS One"},{"key":"R55-20250608","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1758-2652-14-16","article-title":"Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study","volume":"14","author":"Dauby","year":"2011","journal-title":"J Int AIDS Soc"},{"key":"R56-20250608","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1413-8670(11)70211-2","article-title":"Breast cancer in a cohort of human immunodeficiency virus (HIV)-infected women from Rio de Janeiro, Brazil: a cases series report and an incidence rate estimate","volume":"15","author":"Andrade","year":"2011","journal-title":"Braz J Infect Dis"},{"key":"R57-20250608","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1016\/j.ejca.2012.05.019","article-title":"Breast cancer among HIV infected individuals from the ONCOVIH study, in France: therapeutic implications","volume":"48","author":"Spano","year":"2012","journal-title":"Eur J Cancer"},{"key":"R59-20250608","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12992-018-0446-6","article-title":"Improving early detection of breast cancer in sub-Saharan Africa: why mammography may not be the way forward","volume":"15","author":"Black","year":"2019","journal-title":"Glob Health"},{"key":"R60-20250608","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/ijc.24840","article-title":"A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening","volume":"126","author":"Mittra","year":"2010","journal-title":"Int J Cancer"},{"key":"R61-20250608","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1200\/JCO.2017.73.7338","article-title":"Modernizing clinical trial eligibility criteria: recommendations of the American Society of Clinical Oncology\u2013Friends of Cancer Research HIV Working Group","volume":"35","author":"Uldrick","year":"2017","journal-title":"J Clin Oncol"},{"key":"R62-20250608","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jamaoncol.2020.0465","article-title":"Assessment of the feasibility and safety of durvalumab for treatment of solid tumors in patients with HIV-1 infection: the Phase 2 DURVAST Study","volume":"6","author":"Gonzalez-Cao","year":"2020","journal-title":"JAMA Oncol"},{"key":"R63-20250608","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jamaoncol.2019.2244","article-title":"Assessment of the safety of pembrolizumab in patients with HIV and advanced cancer\u2014a phase 1 study","volume":"5","author":"Uldrick","year":"2019","journal-title":"JAMA Oncol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0000000000002810","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T20:06:06Z","timestamp":1749413166000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0000000000002810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,30]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0000000000002810","relation":{},"ISSN":["0269-9370","1473-5571"],"issn-type":[{"value":"0269-9370","type":"print"},{"value":"1473-5571","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,30]]}}}